Navigation Links
Martek Announces Third Quarter 2008 Financial Results
Date:9/4/2008

21,523

Investing activities:

(Purchase) sale of investments and marketable

securities, net (10,850) 6,850

Expenditures for property, plant and equipment (5,587) (5,110)

Proceeds from sale of fluorescent detection

products business - 900

Repurchase from sale-leaseback transaction - (3,910)

Capitalization of intangible assets (3,208) (4,806)

Net cash used in investing activities (19,645) (6,076)

Financing activities:

Repayments of notes payable and other long-term

obligations, net (8,888) (759)

Repayments under revolving credit facility, net - (19,000)

Proceeds from stock option exercises and

other, net 7,243 2,209

Net cash used in financing activities (1,645) (17,550)

Net change in cash, cash equivalents 40,649 (2,103)

Cash and cash equivalents, beginning of period 16,973 15,578

Cash and cash equivalents, end of period $57,622 $13,475

CONTACT

Kyle Stults

Investor Relations

(410) 740-0081

kstults@martek.com


'/>"/>
SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Martek Announces Fourth Quarter and FY 2007 Financial Results
9. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
10. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 01, 2015 , ... A newly launched business plan contest will ask startup ... innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will see ... a period of expert mentorship from a senior industry figure drawn from the Pistoia ...
(Date:7/1/2015)... IN (PRWEB) , ... July 01, 2015 , ... Apex ... 2015 BIO International Convention in Philadelphia, PA. , The presentation took place ... and outlined the plans for the development of APX3330 for the treatment of pancreatic ...
(Date:7/1/2015)... NEW YORK , July 1, 2015 /PRNewswire/ ... G ), a global leader in designing, ... the Aecus Innovation Award in recognition of their ... operational efficiencies in UCB,s global business services (GBS) ... acknowledge service providers and clients that work together ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... to take part in the first half of “Integrative Biotechnology,” an applied biotechnology ... established in summer 2014, this course combines students from both universities and is ...
Breaking Biology Technology:Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2
... Germany, April 29 , - Strong ... - Annual General Meeting Passes Dividend of EUR0.40 ... of Gerresheimer AG today passed an unchanged,dividend of EUR0.40 per share ... The Company finished the financial year 2008 with record results.,Gerresheimer achieved ...
... Data for Ipilimumab to be Presented -PRINCETON, N.J., April ... announced today that the following clinical abstracts for ipilimumab ... an anti-PD-1 antibody for cancer treatment, have been selected ... Meeting of the American Society of Clinical Oncology, being ...
... effort to provide technology to reduce healthcare-associated infections, ... device company, has demonstrated its patented ultra-fast (1 ... to protect hospital patients and medical professionals from ... It enables effective, frequent and instantaneous hygiene practice ...
Cached Biology Technology:2008 a Record Year for Gerresheimer 2Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 2Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 3Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 4Germgard's Ultra-Fast Hand Hygiene Solution Protects Against Deadly MRSA, C difficile, and Influenza Virus 2
(Date:6/17/2015)... , Deutschland und GERMANTOWN, Maryland , ... ®   Produktlinie mit DNA-Tests verbessert ... N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) ... neue STR-Testkits der Produktlinie Investigator ® ... den Markt eingeführt. Die neuen Kits zur Erstellung genetischer ...
(Date:6/16/2015)... June 16, 2015  With the increasing number and ... a top concern. The recent compromise of Federal ... for strong authentication within government agencies. HYPR ... one-time password (OTP) authenticator, has been submitted for testing ... Level 3 validation for tamper proofing. ...
(Date:6/15/2015)... , Jun. 15, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, announces that its ... showcased to media at Digital Experience! @ NYC June 18th. ... showcase of the latest innovation in technology to over 300 ... be held at the Metropolitan Pavilion in New ...
Breaking Biology News(10 mins):QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
... In roughly five to ten percent of breast cancer cases there ... genetic factors play a role here. Alterations in the genes known ... cancer these are responsible for roughly 25 percent of such ... are not attributable to mutations in BRCAI and BRCAII. We assume ...
... 13, 2008 Data published today in The Lancet ... fully bioabsorbable drug eluting stent for the treatment of ... driven target lesion revascularizations (re-treatment of a diseased lesion), ... cardiac events (MACE) in 30 patients out to one ...
... Crop scientists have cloned a gene that controls the ... mystery behind the huge morphological differences among edible fruits and ... plant development. The gene, dubbed SUN, is only the ... elongated shape of various tomato varieties, said Esther van der ...
Cached Biology News:Gene variant increases breast cancer risk 2The Lancet publishes first clinical trial data of a fully bioabsorbable drug eluting stent 2Crop scientists discover gene that controls fruit shape 2Crop scientists discover gene that controls fruit shape 3Crop scientists discover gene that controls fruit shape 4
ANTI MYCOBACTERIUM TUBERCULOSIS...
IMAGEQUANT 100 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
IMAGEQUANT 300 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
Recombinant Feline IL-12/IL-23 p40 (C-Terminus), CF...
Biology Products: